Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

Compare

58 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHTDF Analyst Ratings

Currently, no data available

Based on NaN analysts giving stock ratings to

Sinopharm

Group Co

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHTDF Stock 12 Month Forecast

There Are No Analyst Ratings for SHTDF In The Last 3 Months.

Highest Price Target―

Average Price Target―

Lowest Price Target―

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SHTDF Financial Forecast

SHTDF Earnings Forecast

Next quarter’s earnings estimate for SHTDF is $0.17 with a range of $0.17 to $0.17. The previous quarter’s EPS was $0.09. SHTDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year SHTDF has Performed in-line its overall industry.

SHTDF Sales Forecast

Next quarter’s sales forecast for SHTDF is $41.04B with a range of $41.04B to $41.04B. The previous quarter’s sales results were ―. SHTDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year SHTDF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts

Unknown Analyst

HSBC

Not Ranked

HSBC

$2.3→$2.49

Sell

-4.78%

Downside

Reiterated

11/10/25

HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)

Unknown Analyst

UBS

Not Ranked

UBS

$3.1

Buy

18.18%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

$2.69

Buy

2.55%

Upside

Reiterated

10/27/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.73

Buy

4.01%

Upside

Reiterated

09/26/25

Unknown Analyst

CICC

Not Ranked

CICC

$3.16

Buy

20.62%

Upside

Reiterated

08/27/25

Unknown Analyst

Citi

Not Ranked

Citi

$2.9

Buy

10.85%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

$2.21

Sell

-15.52%

Downside

Reiterated

08/26/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

$3.02

Buy

15.25%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$2.94

Buy

12.32%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

$2.88

Buy

9.87%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

$2.81

Buy

7.43%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.88

Buy

10.07%

Upside

Reiterated

04/02/25

Jialin Zhang

Nomura

$3.21→$2.99

Buy

14.27%

Upside

Reiterated

03/25/25

Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$23.40 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$23.40 (from HK$25.09) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

HSBC

Not Ranked

HSBC

$2.3→$2.49

Sell

-4.78%

Downside

Reiterated

11/10/25

HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)

Unknown Analyst

UBS

Not Ranked

UBS

$3.1

Buy

18.18%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

$2.69

Buy

2.55%

Upside

Reiterated

10/27/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.73

Buy

4.01%

Upside

Reiterated

09/26/25

Unknown Analyst

CICC

Not Ranked

CICC

$3.16

Buy

20.62%

Upside

Reiterated

08/27/25

Unknown Analyst

Citi

Not Ranked

Citi

$2.9

Buy

10.85%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

$2.21

Sell

-15.52%

Downside

Reiterated

08/26/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

$3.02

Buy

15.25%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$2.94

Buy

12.32%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

$2.88

Buy

9.87%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

$2.81

Buy

7.43%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.88

Buy

10.07%

Upside

Reiterated

04/02/25

Jialin Zhang

Nomura

$3.21→$2.99

Buy

14.27%

Upside

Reiterated

03/25/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+10.95%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.95% per trade.

1 Year

Laurence TamMorgan Stanley

Success Rate

3/4 ratings generated profit

Average Return

+2.15%

reiterated a buy rating 6 months ago

Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +2.15% per trade.

2 Years

xxx

Success Rate

3/4 ratings generated profit

Average Return

+3.85%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +3.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHTDF Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHTDF has received 17 Buy Ratings, 31 Hold Ratings, and 2 Sell Ratings. SHTDF average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

SHTDF Stock Forecast FAQ

What is SHTDF’s average 12-month price target, according to analysts?

Currently, no data Available

What is SHTDF’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for SHTDF, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SHTDF a Buy, Sell or Hold?

Currently, no data Available

What is Sinopharm Group Co Ltd Class H’s price target?

Currently, no data Available

What do analysts say about Sinopharm Group Co Ltd Class H?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of SHTDF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

SHTDF Analyst Ratings

SHTDF Stock 12 Month Forecast

SHTDF Financial Forecast

SHTDF Earnings Forecast

SHTDF Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Sinopharm Group Co

SHTDF Analyst Recommendation Trends

SHTDF Stock Forecast FAQ

Detailed List of Analyst Forecasts